Clarke D, Katoh O, Gibbs R V, Griffiths S D, Gordon M Y
Leukaemia Research Fund Centre, Institute of Cancer Research, London, UK.
Cytokine. 1995 May;7(4):325-30. doi: 10.1006/cyto.1995.0041.
We have investigated the binding of interleukin 7 (IL-7) to sulfated glycosaminoglycans and evaluated its biological consequences. IL-7 binds to heparin and heparan sulfate, to a lesser extent to dermatan sulfate and does not bind to chondroitin sulfate. It was eluted from heparin by 0.3-0.6 M NaCl and from heparan sulfate by < 0.3 M NaCl. We also measured the affinity of IL-7 for heparin using an affinity co-electrophoresis method and found an affinity of 25 nM. In spite of these findings, IL-7 does not bind to the S17 cell line which supports lymphopoiesis. However, addition of heparin to cultures of an IL-7-dependent pre-B cell line (2E8) inhibited IL-7-stimulated proliferation and IL-7 complexed with heparin was more resistant than free IL-7 to protease treatment. Taken together, these results suggest that heparin may act as a carrier for IL-7, blocking its interaction with target cells and protecting it from degradation during transit.
我们研究了白细胞介素7(IL-7)与硫酸化糖胺聚糖的结合,并评估了其生物学后果。IL-7与肝素和硫酸乙酰肝素结合,与硫酸皮肤素的结合程度较低,与硫酸软骨素不结合。它在0.3 - 0.6 M NaCl溶液中从肝素上洗脱,在< 0.3 M NaCl溶液中从硫酸乙酰肝素上洗脱。我们还使用亲和共电泳方法测量了IL-7对肝素的亲和力,发现其亲和力为25 nM。尽管有这些发现,但IL-7不与支持淋巴细胞生成的S17细胞系结合。然而,向依赖IL-7的前B细胞系(2E8)培养物中添加肝素会抑制IL-7刺激的增殖,并且与肝素复合的IL-7比游离IL-7对蛋白酶处理更具抗性。综上所述,这些结果表明肝素可能作为IL-7的载体,阻断其与靶细胞的相互作用,并在转运过程中保护其免受降解。